Business Wire5h
BPGbio to Present Novel Drug Target for Huntington’s Disease and AI Discovered Biomarkers for Alzheimer’s Disease at Society for Neuroscience 2024
BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.
GlobalData on MSN1d
BPGbio’s mitochondrial disorder drug gets paediatric disease status
BPM31510IV is also a lead candidate to treat solid tumours such as glioblastoma multiforme and pancreatic cancer.
Pharmabiz1d
BPGbio receives US FDA rare paediatric disease designation for BPM31510IV for primary coenzyme Q10 deficiency treatment
Boston, Massachusetts Tuesday, October 1, 2024, 14:00 Hrs [IST] ...
BPGbio and Joslin Diabetes Center Announce Publication Showing Game-Changing Effects of Blue Light in the Reduction of Fat Cells
BPGbio and Joslin Diabetes Center announce Nature Communications publication showing game-changing effects of blue light in ...
Hosted on MSN7mon
Biotech Company Leaving Framingham Headquarters For Waltham
WALTHAM, MA — A biotech company is leaving Framingham behind for the new Third Avenue life science building in Waltham. BPGbio announced this week that a lease agreement was reached for 70,000 sq.
BPGbio Appoints John Beeler as SVP of Business Development
BPGbio Enhances Commercial Capabilities with Industry Veteran Addition. BOSTON, September 16, 2024--(BUSINESS WIRE)--BPGbio, ...
Joplin Globe20d
BPGbio Presents Phase 2b BPM31510 Glioblastoma Trial-in-Progress Update and Pioneering Comprehensive Quinomics Assessment at the ESMO Congress 2024
BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced that researchers will present two posters on ...
Eagle-Tribune1mon
BPGbio to Present on its First-in-Class E2-based Approach to Targeted Protein Degradation at 15th Annual Drug Innovation Forum
BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced that Vivek K. Vishnudas, Ph.D., Chief ...
MM&M13d
The Escalator: Imre, Kyverna Therapeutics, The Bloc and more
Kyverna Therapeutics named Warner Biddle as CEO. Trailhead Biosystems hired Joshua Snow as chief commercial officer. BPGbio ...
Joplin Globe7d
BPGbio and Joslin Diabetes Center Announce Publication Showing Game-Changing Effects of Blue Light in the Reduction of Fat Cells
BPGbio, a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, and Joslin Diabetes Center, the world's leading diabetes ...
Business Wire16d
BPGbio Appoints John Beeler as SVP of Business Development
BOSTON--(BUSINESS WIRE)--BPGbio, Inc., a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, today announced the ...